Cas 7641-85-2,1-(4-(hexan-2-yl)phenyl)ethan-1-one

7641-85-2

Post Buying Request

Basic information

Product Name: 1-(4-(hexan-2-yl)phenyl)ethan-1-one
Synonyms: 1-(4-(hexan-2-yl)phenyl)ethan-1-one
CAS NO:7641-85-2
Molecular Formula:
Molecular Weight: 204.312
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1-(4-(hexan-2-yl)phenyl)ethan-1-one(CAS DataBase Reference)
NIST Chemistry Reference: 1-(4-(hexan-2-yl)phenyl)ethan-1-one(7641-85-2)
EPA Substance Registry System: 1-(4-(hexan-2-yl)phenyl)ethan-1-one(7641-85-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 7641-85-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

7641-85-2 Suppliers

Recommended suppliers

7641-85-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7641-85-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,6,4 and 1 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 7641-85:
(6*7)+(5*6)+(4*4)+(3*1)+(2*8)+(1*5)=112
112 % 10 = 2
So 7641-85-2 is a valid CAS Registry Number.

7641-85-2Upstream product

7641-85-2Downstream Products

7641-85-2Relevant academic research and scientific papers

Ni-catalyzed Reductive Deaminative Arylation at sp3 Carbon Centers

Martin-Montero, Raul,Yatham, Veera Reddy,Yin, Hongfei,Davies, Jacob,Martin, Ruben

, p. 2947 - 2951 (2019/04/30)

A Ni-catalyzed reductive deaminative arylation at unactivated sp3 carbon centers is described. This operationally simple and user-friendly protocol exhibits excellent chemoselectivity profile and broad substrate scope, thus complementing existing metal-catalyzed cross-coupling reactions to forge sp3 C-C linkages. These virtues have been assessed in the context of late-stage functionalization, hence providing a strategic advantage to reliably generate structure diversity with amine-containing drugs.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 7641-85-2